1 |
SUN H, SAEEDI P, KARURANGA S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183: 109119.
|
2 |
NAUCK M A, WEFERS J, MEIER J J. Treatment of type 2 diabetes: challenges, hopes, and anticipated successes[J]. Lancet Diabetes Endocrinol, 2021, 9(8): 525-544.
|
3 |
HANNON T S, KAHN S E, UTZSCHNEIDER K M, et al. Review of methods for measuring β-cell function: design considerations from the Restoring Insulin Secretion (RISE) Consortium[J]. Diabetes Obes Metab, 2018, 20(1): 14-24.
|
4 |
CĂTOI A F, BUSETTO L. Metabolically healthy obesity and bariatric surgery[J]. Obes Surg, 2019, 29(9): 2989-3000.
|
5 |
KIM E H, KIM H K, LEE M J, et al. Sex differences of visceral fat area and visceral-to-subcutaneous fat ratio for the risk of incident type 2 diabetes mellitus[J]. Diabetes Metab J, 2022, 46(3): 486-498.
|
6 |
GYLLENHAMMER L E, ALDERETE T L, TOLEDO-CORRAL C M, et al. Saturation of subcutaneous adipose tissue expansion and accumulation of ectopic fat associated with metabolic dysfunction during late and post-pubertal growth[J]. Int J Obes (Lond), 2016, 40(4): 601-606.
|
7 |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409.
|
|
Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition)[J]. Chinese Journal of Diabetes, 2021, 13(4): 315-409.
|
8 |
TER HORST K W, VAN GALEN K A, GILIJAMSE P W, et al. Methods for quantifying adipose tissue insulin resistance in overweight/obese humans[J]. Int J Obes (Lond), 2017, 41(8): 1288-1294.
|
9 |
朱小鹏, 颜红梅, 常薪霞, 等. 精氨酸刺激试验评估胰岛β细胞1相分泌功能的价值及对2型糖尿病治疗的指导作用[J]. 中国临床医学, 2017, 24(4): 548-553.
|
|
ZHU X P, YAN H M, CHANG X X, et al. The value of arginine stimulation test in evaluating the first-phase insulin secretion and its guiding role for the treatment of type 2 diabetes mellitus[J]. Chinese Journal of Clinical Medicine, 2017, 24(4): 548-553.
|
10 |
SASSO M, BEAUGRAND M, DE LEDINGHEN V, et al. Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes[J]. Ultrasound Med Biol, 2010, 36(11): 1825-1835.
|
11 |
SMITH U, KAHN B B. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids[J]. J Intern Med, 2016, 280(5): 465-475.
|
12 |
LI R, LU W, JIA J, et al. Relationships between indices of obesity and its cardiovascular comorbidities in a Chinese population[J]. Circ J, 2008, 72(6): 973-978.
|
13 |
NEELAND I J, TURER A T, AYERS C R, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults[J]. JAMA, 2012, 308(11): 1150-1159.
|
14 |
LI H T, WU G Y, FANG Q C, et al. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat[J]. Nat Commun, 2018, 9(1): 272.
|
15 |
陈姝, 储爱卉, 卞文轩, 等. 2型糖尿病患者骨骼肌质量与胰岛功能相关性研究[J]. 中国临床研究, 2024, 37(7): 1045-1050.
|
|
CHEN S, CHU A H, BIAN W X, et al. Correlation between skeletal muscle mass and islet function in patients with type 2 diabetes mellitus[J]. Chinese Journal of Clinical Research, 2024, 37(7): 1045-1050.
|
16 |
SYED I, RUBIN DE CELIS M F, MOHAN J F, et al. PAHSAs attenuate immune responses and promote β cell survival in autoimmune diabetic mice[J]. J Clin Invest, 2019, 129(9): 3717-3731.
|
17 |
SUN Y C, ZHU Y Q, ZHANG L, et al. Relationship between insulin secretion and arterial stiffness in essential hypertension[J]. Int J Hypertens, 2021, 2021: 5015797.
|
18 |
ZHENG M Y, ZHANG X Y, CHEN S H, et al. Arterial stiffness preceding diabetes: a longitudinal study[J]. Circ Res, 2020, 127(12): 1491-1498.
|
19 |
NIE F Z, HE J A, CAO H, et al. Predictive value of abnormal ankle-brachial index in patients with diabetes: a meta-analysis[J]. Diabetes Res Clin Pract, 2021, 174: 108723.
|
20 |
TEIXEIRA P F D S, DOS SANTOS P B, PAZOS-MOURA C C. The role of thyroid hormone in metabolism and metabolic syndrome[J]. Ther Adv Endocrinol Metab, 2020, 11: 2042018820917869.
|
21 |
MORAN C, MCENIERY C M, SCHOENMAKERS N, et al. Dyslipidemia, insulin resistance, ectopic lipid accumulation, and vascular function in resistance to thyroid hormone β[J]. J Clin Endocrinol Metab, 2021, 106(5): e2005-e2014.
|
22 |
YAN Y, NIU Z M, SUN C, et al. Hepatic thyroid hormone signalling modulates glucose homeostasis through the regulation of GLP-1 production via bile acid-mediated FXR antagonism[J]. Nat Commun, 2022, 13(1): 6408.
|
23 |
VERGA FALZACAPPA C, PETRUCCI E, PATRIARCA V, et al. Thyroid hormone receptor TRβ1 mediates Akt activation by T3 in pancreatic β cells[J]. J Mol Endocrinol, 2007, 38(1/2): 221-233.
|
24 |
VERGA FALZACAPPA C, PATRIARCA V, BUCCI B, et al. The TRβ1 is essential in mediating T3 action on Akt pathway in human pancreatic insulinoma cells[J]. J Cell Biochem, 2009, 106(5): 835-848.
|